| Literature DB >> 35281345 |
Nana Shen1, Xiaolin Wu2, Zhu Guo2, Shuai Yang2, Chang Liu2, Zhaoyang Guo2, Shang-You Yang3, Dongming Xing4, Bohua Chen2, Hongfei Xiang2.
Abstract
Objective: Through the follow-up analysis of cervical spine fracture cases with ankylosing spondylitis (AS), a treatment-oriented fracture classification method is introduced to evaluate the clinical efficacy guided by this classification method. Method: A retrospective analysis was performed on 128 AS patients who underwent comprehensive treatment in the Spine Surgery Department of Qingdao University Hospital from January 2009 to May 2018. Statistics of patient demographic data, distribution of different fractures corresponding to surgical methods, 3-year follow-up outcomes, and summary of objective fracture classification methods were analyzed. A prospective 5-year follow-up study of 90 patients with AS cervical spine fractures from June 2015 to August 2020 was also included. Statistical differences on the distribution of factors such as case information, cervical spine sagittal sequence parameters, and fracture classification were assessed. Correlations between surgical information, American Spinal Injuries Association grade (ASIA), modified Japanese Orthopaedic Association scores (mJOA), and other factors were analyzed to establish a nomogram predictive model for curative effect outcomes. Overall, three major types and the four subtypes of AS cervical spine fractures were evaluated based on the clinical efficacy of the classification and the selection of surgical treatment methods. Result: The most common type of fracture was type II (30 cases, 33.33%), most of the subtypes were A (37 cases), followed by B (36 cases) and C (17 cases). Twenty-four of 28 patients with type I underwent anterior surgery, and 47 of 62 patients with type II and III underwent posterior surgery. The average follow-up time was 25.76 ± 11.80 months. The results of predicting clinical variables are different but include factors such as fracture type and subtype, type of operation, and age. The predictor variables include the above-mentioned similar variables, but survival is more affected by the fracture type of the patient.Entities:
Mesh:
Year: 2022 PMID: 35281345 PMCID: PMC8916892 DOI: 10.1155/2022/7769775
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1Fracture classification.
Figure 2Treatment basis diagram.
Basic information.
| Variable |
| Total number |
|---|---|---|
| Sex | 90 | |
|
| 9 (10%) | |
|
| 81 (90%) | |
|
| ||
| Age | 90 | |
|
| 20 (22.2%) | |
|
| 70 (77.8%) | |
|
| ||
| BMI | 90 | |
|
| 46 (51.1%) | |
|
| 44 (48.9%) | |
|
| ||
| Smoking | 90 | |
|
| 34 (37.8%) | |
|
| 56 (62.2%) | |
|
| ||
| COBB | 90 | |
|
| 58 (64.4%) | |
|
| 32 (35.6%) | |
|
| ||
| cSVA | 7.8 (6.25–9.15) | 89 |
|
| 34.2 (30.05–38) | |
|
| ||
| Fracture site | 6 (2–8) | 90 |
|
| 27 (30%) | |
|
| 63 (70%) | |
|
| ||
| Fracture type | 90 | |
|
| 28 (31.1%) | |
|
| 30 (33.3%) | |
|
| 32 (35.6%) | |
|
| ||
| Subtype | 90 | |
|
| 37 (41.1%) | |
|
| 36 (40%) | |
|
| 17 (18.9%) | |
|
| ||
| Preoperative ASIA | 90 | |
|
| 47 (52.2%) | |
|
| 43 (47.8%) | |
|
| ||
| Preoperative mJOA | 90 | |
|
| 155 (120–210) | 81 |
|
| 300 (150–500) | 81 |
|
| ||
| Treatment | 90 | |
|
| 48 (53.3%) | |
|
| 3 (3.3%) | |
|
| 8 (8.9%) | |
|
| 31 (34.4%) | |
Figure 3Statistics of fracture types and treatment methods.
Figure 4Prediction of clinical outcomes of main classification (survival curve).
Figure 5Prediction of subtype clinical outcomes (survival curve).
Figure 6Predictive evaluation nomogram for fracture classification and clinical evaluation.
Figure 7Calibration curve for one-year survival prediction.
Logistic and ASIA.
| Variable | Unadjusted OR (95% CI) |
| Adjusted OR (95% CI) |
|
|---|---|---|---|---|
| Sex (female vs. male) | 0.51 (0.1–2.63) | 0.423 | ||
| Age (≥60 vs. <60) | 7.28 (2.42–21.88) | 0 | 2.31 (0.35–15.21) | 0.383 |
| BMI (≥25 vs. <25) | 0.3 (0.12–0.76) | 0.011 | 0.26 (0.06–1.2) | 0.084 |
| Smoking (yes vs. no) | 0.69 (0.28–1.73) | 0.435 | ||
| COBB score (≥10° vs. <10°) | 1.01 (0.41–2.49) | 0.992 | ||
| cSVA (every 1 increment) | 1.2 (1–1.43) | 0.051 | 1.23 (0.89–1.69) | 0.205 |
|
| 0.94 (0.87–1.03) | 0.187 | ||
| Fracture site (single vs. multiple) | 0.16 (0.04–0.57) | 0.005 | — | — |
| Fracture type | <0.001 | 0.821 | ||
|
| Reference | Reference | ||
|
| 0.33 (0.08–1.45) | 0.142 | — | — |
|
| 5.73 (1.86–17.63) | 0.002 | 1.8 (0.29–11.35) | 0.53 |
| Subtype | 0.072 | 0.869 | ||
|
| Reference | Reference | ||
|
| 1.19 (0.43–3.28) | 0.739 | 1 (0.17–6.08) | 0.997 |
|
| 3.86 (1.15–12.91) | 0.029 | 1.64 (0.23–11.44) | 0.62 |
| ASIA (A, B, and C vs. D and E) | 74.12 (9.35–587.66) | <0.001 | 40.52 (3.79–433.73) | 0.002 |
| mJOA (every 1 increment) | 0.68 (0.57–0.81) | <0.001 | 0.91 (0.69–1.2) | 0.495 |
| Treatment | ||||
|
| Reference | 0.741 | ||
|
| 1.34 (0.51–3.56) | 0.556 | ||
|
| 1.22 (0.1–15.23) | 0.876 | ||
|
| 2.44 (0.5–11.97) | 0.27 |
Logistic and mJOA.
| Variable | Unadjusted OR (95% CI) |
| Adjusted OR (95% CI) |
|
|---|---|---|---|---|
| Sex (female vs. male) | 1 (0.25–4) | 1 | ||
| Age (≥60 vs. <60) | 10.69 (2.3–49.59) | 0.002 | 4.73 (0.45–49.46) | 0.194 |
| BMI (≥25 vs. <25) | 0.76 (0.33–1.74) | 0.51 | ||
| Smoking (yes vs. no) | 0.47 (0.2–1.13) | 0.091 | 0.24 (0.06–0.95) | 0.043 |
| COBB score (≥10° vs. <10°) | 0.96 (0.4–2.28) | 0.922 | ||
| cSVA (every 1 increment) | 0.95 (0.8–1.11) | 0.507 | ||
|
| 0.99 (0.92–1.07) | 0.821 | ||
| Fracture site (single vs. multiple) | 0.21 (0.08–0.56) | 0.002 | 0.05 (0–1.28) | 0.07 |
| Fracture type | 0.003 | 0.538 | ||
|
| Reference | Reference | ||
|
| 0.33 (0.08–1.45) | 0.142 | 3.68 (0.15–88.42) | 0.421 |
|
| 5.73 (1.86–17.63) | 0.002 | 0.61 (0.1–3.56) | 0.578 |
| Subtype | 0.001 | 0.053 | ||
|
| Reference | 0.04 | Reference | |
|
| 1.19 (0.43–3.28) | 0.739 | 2.29 (0.56–9.37) | 0.25 |
|
| 3.86 (1.15–12.91) | 0.029 | 16.73 (1.62–172.93) | 0.018 |
| ASIA (A, B, and C vs. D and E) | 8.54 (3.29–22.18) | <0.001 | 2.93 (0.75–11.45) | 0.123 |
| mJOA (every 1 increment) | 0.64 (0.54–0.77) | <0.001 | 0.65 (0.5–0.84) | 0.001 |
| Treatment | ||||
|
| Reference | 0.866 | ||
|
| 1.06 (0.43–2.63) | 0.902 | ||
|
| 0.41 (0.03–5.03) | 0.487 | ||
|
| 1.37 (0.28–6.78) | 0.697 |
COX and OS.
| Variable | Unadjusted HR (95% CI) |
| Adjusted HR (95% CI) |
|
|---|---|---|---|---|
| Sex (female vs. male) | 0.04 (0–130.87) | 0.44 | ||
| Age (≥60 vs. <60) | 13.09 (3.53–48.49) | 0 | 2.93 (0.6–14.32) | 0.185 |
| BMI (≥25 vs. <25) | 0.46 (0.14–1.53) | 0.205 | ||
| Smoking (yes vs. no) | 1.2 (0.38–3.78) | 0.756 | ||
| COBB score (≥10° vs. <10°) | 0.38 (0.12–1.21) | 0.101 | ||
| cSVA (every 1 increment) | 1.01 (0.81–1.26) | 0.931 | ||
|
| 0.95 (0.85–1.07) | 0.381 | ||
| Fracture site (single vs. multiple) | 0.2 (0.03–1.55) | 0.124 | ||
| Fracture type | 0.01 | 0.59 | ||
|
| Reference | Reference | ||
|
| 0.95 (0.06–15.17) | 0.971 | 0.55 (0.03–11.43) | 0.701 |
|
| 10.33 (1.32–80.74) | 0.026 | 1.65 (0.14–19.59) | 0.69 |
| Subtype | 0.001 | 0.085 | ||
|
| Reference | Reference | ||
|
| 3.16 (0.33–30.33) | 0.32 | 3.01 (0.3–29.73) | 0.346 |
|
| 21.47 (2.68–171.94) | 0.004 | 9.24 (1.04–82.06) | 0.046 |
| ASIA (A, B, and C vs. D and E) | 11.46 (1.48–88.85) | 0.02 | 1.46 (0.11–18.56) | 0.773 |
| mJOA (every 1 increment) | 0.63 (0.47–0.83) | 0.001 | 0.77 (0.53–1.11) | 0.155 |
| Treatment | 0.741 | |||
|
| Reference | |||
|
| 172324.78 (0–2.994 | 0.941 | ||
|
| — | — | ||
|
| 386706.5 (0–6.727 | 0.937 |
Figure 8Type I fracture. An anterior approach is adopted. The length of the plate should be extended by more than two segments.
Figure 9Treatment of type IIA; most fracture patients can be treated with posterior surgery, which is safer.